T-cell epitope peptide vaccines

Sherine F. Elsawa, David A. Rodeberg, Esteban Celis

Research output: Contribution to journalReview article

21 Citations (Scopus)

Abstract

T-cell immunotherapy is a promising treatment option for cancer. The identification of tumor antigens that are recognized by the immune system has allowed for the generation of vaccines for various malignancies. Due to the ease of manufacturing and characterizating peptide-based vaccines they have been used to stimulate antitumor T-cells. This article will review the use of peptide-based vaccines for the treatment of cancer by inducing antitumor T-lymphocyte responses.

Original languageEnglish (US)
Pages (from-to)563-575
Number of pages13
JournalExpert Review of Vaccines
Volume3
Issue number5
DOIs
StatePublished - Oct 1 2004

Fingerprint

Subunit Vaccines
T-Lymphocyte Epitopes
T-Lymphocytes
Neoplasms
Neoplasm Antigens
Immunotherapy
Immune System
Vaccines
Therapeutics

Keywords

  • Cancer
  • Peptide vaccines
  • T-cell epitopes

ASJC Scopus subject areas

  • Immunology
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Cite this

T-cell epitope peptide vaccines. / Elsawa, Sherine F.; Rodeberg, David A.; Celis, Esteban.

In: Expert Review of Vaccines, Vol. 3, No. 5, 01.10.2004, p. 563-575.

Research output: Contribution to journalReview article

Elsawa, Sherine F. ; Rodeberg, David A. ; Celis, Esteban. / T-cell epitope peptide vaccines. In: Expert Review of Vaccines. 2004 ; Vol. 3, No. 5. pp. 563-575.
@article{5c3c4f5f440e41ad96c3d9186265b80b,
title = "T-cell epitope peptide vaccines",
abstract = "T-cell immunotherapy is a promising treatment option for cancer. The identification of tumor antigens that are recognized by the immune system has allowed for the generation of vaccines for various malignancies. Due to the ease of manufacturing and characterizating peptide-based vaccines they have been used to stimulate antitumor T-cells. This article will review the use of peptide-based vaccines for the treatment of cancer by inducing antitumor T-lymphocyte responses.",
keywords = "Cancer, Peptide vaccines, T-cell epitopes",
author = "Elsawa, {Sherine F.} and Rodeberg, {David A.} and Esteban Celis",
year = "2004",
month = "10",
day = "1",
doi = "10.1586/14760584.3.5.563",
language = "English (US)",
volume = "3",
pages = "563--575",
journal = "Expert Review of Vaccines",
issn = "1476-0584",
publisher = "Expert Reviews Ltd.",
number = "5",

}

TY - JOUR

T1 - T-cell epitope peptide vaccines

AU - Elsawa, Sherine F.

AU - Rodeberg, David A.

AU - Celis, Esteban

PY - 2004/10/1

Y1 - 2004/10/1

N2 - T-cell immunotherapy is a promising treatment option for cancer. The identification of tumor antigens that are recognized by the immune system has allowed for the generation of vaccines for various malignancies. Due to the ease of manufacturing and characterizating peptide-based vaccines they have been used to stimulate antitumor T-cells. This article will review the use of peptide-based vaccines for the treatment of cancer by inducing antitumor T-lymphocyte responses.

AB - T-cell immunotherapy is a promising treatment option for cancer. The identification of tumor antigens that are recognized by the immune system has allowed for the generation of vaccines for various malignancies. Due to the ease of manufacturing and characterizating peptide-based vaccines they have been used to stimulate antitumor T-cells. This article will review the use of peptide-based vaccines for the treatment of cancer by inducing antitumor T-lymphocyte responses.

KW - Cancer

KW - Peptide vaccines

KW - T-cell epitopes

UR - http://www.scopus.com/inward/record.url?scp=7444251645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7444251645&partnerID=8YFLogxK

U2 - 10.1586/14760584.3.5.563

DO - 10.1586/14760584.3.5.563

M3 - Review article

C2 - 15485336

AN - SCOPUS:7444251645

VL - 3

SP - 563

EP - 575

JO - Expert Review of Vaccines

JF - Expert Review of Vaccines

SN - 1476-0584

IS - 5

ER -